Science Drives Everything
With 25,000 clinical researchers testing every day and cutting-edge innovations, our science holds the cure
Despite fewer people smoking and effective therapies for hypertension and high cholesterol, cardiovascular disease remains the number one cause of death worldwide1.
This epidemic is driven by demographic factors like an aging population, decreasing mortality from other factors (such as infectious disease), and rising rates of obesity—which can drive the progression of metabolic diseases, such as Type 2 diabetes, and lead to the “metabolic syndrome,” a constellation of risk factors that increase an individual’s risk for heart disease and other health problems1.
For more than 50 years, we have led the way in redefining the management of cardiovascular risk by bringing much-needed treatments to patients2.
In cardiovascular therapy area, our endeavours have been to disseminate recent updates in Atrial fibrillation (AF) and venous thromboembolism (VTE) to healthcare professionals, and create awareness on the nuances in the management of stroke prevention in AF and treatment of VTE. AF and VTE are common conditions among older adults. Over their lifetime, approximately 1 in 4 individuals will experience AF,while 1 in 8 will develop VTE3. Our initiatives helped address practical challenges faced by a physician while initiating an oral anticoagulant in patients with AF and VTE.
Our early discovery efforts focus on emerging areas of cardiovascular research such as control of eating disorders, Type 2 diabetes/ muscle uptake of glucose and non-alcoholic fatty liver disease/non-alcoholic steatohepatitis2.
Mental Health: Malaysia's 1st mental health handbook launched
According to the National Health Morbidity Survey in 2015, the prevalence of mental health problems among adults and children were 29.2% and 12.1%, respectively4. On top of that, the global outbreak of novel coronavirus disease (COVID-19) in the past years is expected to cause many of us to suffer from the short-term and long-term health effects of stress, anxiety, and other mental health complications5.
Also, due to government-issued quarantine laws and social distancing, many others who aren’t directly affected by the disease may suffer from the indirect consequences of self-isolation, such as depression and post-traumatic stress disorder5.
Mental illness does not discriminate. It can affect anyone regardless of age, gender, race, social status or income4. Those suffering from mental disorders are usually perceived to be restless, violent and unpredictable4. Such stigma and discrimination will only prevent such individuals from seeking professional help and treatment early4.
The Malaysian Psychiatric Association (MPA) and Malaysian Mental Health Association (MMHA) , supported by Pfizer Malaysia, jointly launched a new mental health handbook in December 2019 that aims to provide a credible reference resource guide to enable Malaysians to acquire some basic knowledge about mental health and recognize the early warning signs and symptoms of the various mental disorders.
Learning to cope with mental health issues is difficult and overwhelming, but it can be done. We hope this handbook will significantly improve the lives of individuals with mental illness through better understanding, acceptance, and respect.
1 Pfizer website. Science. Areas of Focus. Internal Medicine: Innovating to Impact Millions. Last accessed on 2 April 2022. Retrieved from: https://www.pfizer.com/science/focus-areas/internal-medicine
2 Pfizer Singapore website. Our Science. Focus Areas. Internal Medicine. Last accessed on 2 April 2022. Retrieved from: https://www.pfizer.com.sg/our-science/focus-areas/internal-medicine
3 Pfizer India website. Our Science. Focus Areas. Internal Medicine. Last accessed on 2 April 2022. Retrieved from: https://www.pfizer.co.in/our-science/focus-areas/internal-medicine
4 Malaysian Psychiatric Association (MPA). Mental Health Handbook. Last accessed on 2 April 2022. Retrieved from: https://www.pfizer.com.my/sites/pfizer.com.my/files/g10061861/f/202109/MentalHealthBooklet-EN.pdf
5 Pfizer website. News. Articles. Managing Your Mental Health During a Pandemic. Last accessed on 2 April 2022. Retrieved from: https://www.pfizer.com/news/articles/managing_your_mental_health_during_a_pandemic